Collins A B, Chicano S L, Cornell L D, Tolkoff-Rubin N, Goes N B, Saidman S L, Farrell M L, Cosimi A B, Colvin R B
Department of Pathology, Medical and Surgical Services of Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA.
Transplant Proc. 2006 Dec;38(10):3427-9. doi: 10.1016/j.transproceed.2006.10.159.
We sought evidence for non-MHC antibody-mediated rejection in renal allografts by a systematic study of rejected HLA-identical sibling renal allografts. Among 162 recipients of HLA-identical, ABO-compatible sibling donor kidneys transplanted at the Massachusetts General Hospital from 1964 to 2005, we identified 15 grafts that were lost from rejection and two additional grafts with reversible acute rejection, which provided 30 samples for study. All samples were stained for C4d by immunofluorescence in frozen tissue (n = 7) or by immunohistochemistry in paraffin embedded tissues (n = 10). We found that two of 17 grafts had positive C4d staining of peritubular capillaries. Histology revealed acute antibody-mediated rejection in one and acute cellular rejection type 1 in the other. Both grafts were matched at HLA-A, B, and C loci and had a nonreactive mixed lymphocyte response. Genotyping and serological analysis were not available. Compared with a published series, C4d+ irreversible rejection was more common in HLA nonidentical than HLA-identical grafts (75% vs 6.7%, respectively, P < .002). We conclude that antibody-mediated rejection, presumably due to non-MHC antigens other than ABO-blood groups does occur, but infrequently. This may account for some of the HLA antibody negative cases that develop antibody-mediated rejection.
我们通过对 HLA 相同的同胞肾移植受者中被排斥的肾移植进行系统研究,寻找非 MHC 抗体介导的肾移植排斥反应的证据。在 1964 年至 2005 年于马萨诸塞州总医院接受 HLA 相同、ABO 相容的同胞供肾移植的 162 名受者中,我们确定了 15 个因排斥反应而丢失的移植物以及另外 2 个发生可逆性急性排斥反应的移植物,共提供了 30 个样本用于研究。所有样本均在冷冻组织中通过免疫荧光法(n = 7)或在石蜡包埋组织中通过免疫组织化学法(n = 10)进行 C4d 染色。我们发现,17 个移植物中有 2 个肾小管周围毛细血管 C4d 染色呈阳性。组织学检查显示,其中 1 个为急性抗体介导的排斥反应,另 1 个为 1 型急性细胞排斥反应。这两个移植物在 HLA - A、B 和 C 位点均匹配,且混合淋巴细胞反应无活性。无法进行基因分型和血清学分析。与已发表的系列研究相比,C4d 阳性的不可逆排斥反应在 HLA 不相同的移植物中比 HLA 相同的移植物中更常见(分别为 75%对 6.7%,P <.002)。我们得出结论,推测由 ABO 血型以外的非 MHC 抗原引起抗体介导的排斥反应确实会发生,但很少见。这可能解释了一些发生抗体介导排斥反应的 HLA 抗体阴性病例。